Under group interaction in cats, a new Soviet tranquilizer mebicar eliminates fear-alarm induced by stimulatin of the emotiogenic zone of the hypothalamus. This action is not associated with myorelaxant or hypnotic action. Mebicar decreases the brain noradrenaline level, exerts no effect on the dopaminergic systems, increases the brain serotonin level, and does not elicit cholinolytic action.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[characteristics psychotropic
4
psychotropic spectrum
4
action
4
spectrum action
4
action mebicar]
4
mebicar] group
4
group interaction
4
interaction cats
4
cats soviet
4
soviet tranquilizer
4

Similar Publications

A cost-effective strategy is reported utilizing ionic liquid (IL), 1-hexyl-3-methylimidazolium bisulfate ([HMIM] HSO), to delaminate TiC MXene, thereby enhancing its efficiency in electrocatalyzing tryptophan (Trp) oxidation. The positively charged IL effectively intercalates within the negatively charged MXene layers, fostering structural stability through π-π stacking and electrostatic interactions. Consequently, the resulting IL-TiC composite not only maintained the inherent electronic conductivity of TiC but also significantly augmented its electrocatalytic prowess.

View Article and Find Full Text PDF

Few Patients Are Treated for Both Obesity and Depression.

South Med J

February 2025

From the Center for Value-Based Care Research, Cleveland Clinic.

Objectives: Understanding the epidemiology of treatment for patients with co-occurring depression and obesity can inform care quality. The objective of the study was to identify how patients with obesity and newly diagnosed depression are treated and whether treatment is associated with body mass index change.

Methods: This cohort study included adults with obesity and newly diagnosed depression who had ≥2 primary care visits between 2015 and 2020 at a large integrated health system.

View Article and Find Full Text PDF

Adolescents with mental illnesses often struggle with adhering to prescribed medication regimens. This study investigates how patient perceptions influence medication adherence among adolescents with psychiatric disorders. It also examines the role of patient characteristics and medication-related factors on adherence and attitudes.

View Article and Find Full Text PDF

Antidepressants versus placebo for generalised anxiety disorder (GAD).

Cochrane Database Syst Rev

January 2025

Department of Psychiatry and Department of Epidemiology and Biostatistics, Western University, St Thomas, Canada.

Background: Generalised anxiety disorder (GAD) is a mental health condition characterised by excessive anxiety and worry about everyday events. GAD is a common disorder and generally affects women twice as often as men. Treatments include various psychological and pharmacological therapies.

View Article and Find Full Text PDF

Characteristics of Trials Preceding FDA Approval of Novel Psychiatric Drugs.

JAMA Netw Open

January 2025

Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!